ENTERIS BIOPHARMA INC has a total of 40 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are NOXOPHARM LTD, BENNIS FARID and LEPU PHARMACEUTICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 12 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | United States | 8 | |
#4 | China | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Fermentation | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Stern William | 23 |
#2 | Vrettos John Stanley | 12 |
#3 | Carl Stephen M | 12 |
#4 | Consalvo Angelo P | 9 |
#5 | Shields Paul | 8 |
#6 | Claudio Raymundo | 8 |
#7 | Vrettos John | 8 |
#8 | Daggs Thomas | 8 |
#9 | Mehta Nozer M | 5 |
#10 | Gilligan James P | 4 |
Publication | Filing date | Title |
---|---|---|
AU2017305415A1 | Room temperature stable oral calcitonin formulation | |
EP3244878A1 | Solid oral dosage forms | |
WO2014138241A1 | Pharmaceuticals for oral delivery | |
AU2006326580A1 | Fast-acting oral peptide pharmaceutical products | |
AU2005201901A1 | Direct expression of peptides into culture media |